Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Five Star Bancorp
FSBC
$1.14B
| $648K | ﹤0.01% |
13,300
-16,000
| -55% | -$675K |
|
2502
Biodesix
BDSX
$281M
| $646K | ﹤0.01% |
28,648
+16,700
| +140% | +$248K |
|
2503
Genesco
GCO
$384M
| $645K | ﹤0.01% |
19,100
+6,700
| +54% | +$235K |
|
2504
Heron Therapeutics
HRTX
$66.4M
| $643K | ﹤0.01% |
1,506,900
-211,400
| -12% | -$170K |
|
2505
Reading International Class A
RDI
$51.5M
| $643K | ﹤0.01% |
502,390
-9,600
| -2% | -$11.1K |
|
2506
Neurogene
NGNE
$763M
| $642K | ﹤0.01% |
20,405
-22,995
| -53% | -$633K |
|
|
LGO
2507
Largo
LGO
$76.3M
| $639K | ﹤0.01% |
1,007,000
-286,300
| -22% | -$295K |
|
2508
US Global Investors
GROW
$35.7M
| $637K | ﹤0.01% |
204,015
+11,300
| +6% | +$30.7K |
|
|
HDV
2509
iShares Core High Dividend ETF
HDV
$15.4B
| $630K | ﹤0.01% |
23,000
-9,000
| -28% | -$245K |
|
2510
Network-1 Technologies
NTIP
$35.9M
| $630K | ﹤0.01% |
428,344
-33,100
| -7% | -$48.5K |
|
2511
loanDepot
LDI
$279M
| $630K | ﹤0.01% |
503,600
-316,200
| -39% | -$426K |
|
2512
Spruce Power Holding Corp
SPRU
$34.3M
| $628K | ﹤0.01% |
243,533
+7,300
| +3% | +$23.8K |
|
|
GRAL
2513
GRAIL Inc
GRAL
$3.53B
| $628K | ﹤0.01% |
9,200
-46,000
| -83% | -$2.71M |
|
2514
AN2 Therapeutics
ANTX
$226M
| $628K | ﹤0.01% |
129,700
-69,100
| -35% | -$297K |
|
|
KE
2515
Kimball Electronics
KE
$605M
| $625K | ﹤0.01% |
+24,432
| New | +$627K |
|
|
PUSA
2516
Aureus Greenway Holdings
PUSA
$98.9M
| $624K | ﹤0.01% |
+156,400
| New | +$656K |
|
2517
iShares Asia 50 ETF
AIA
$5.06B
| $623K | ﹤0.01% |
+4,400
| New | +$578K |
|
2518
First Bank
FRBA
$445M
| $623K | ﹤0.01% |
35,150
-19,438
| -36% | -$312K |
|
|
MDV
2519
DELISTED
Modiv Industrial
MDV
| $623K | ﹤0.01% |
35,800
-39,900
| -53% | -$685K |
|
2520
First Seacoast Bancorp
FSEA
$80.9M
| $623K | ﹤0.01% |
36,932
+15,300
| +71% | +$229K |
|
2521
Tecnoglass Holdings
TGLS
$1.79B
| $623K | ﹤0.01% |
+13,300
| New | +$575K |
|
2522
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.7B
| $621K | ﹤0.01% |
+12,100
| New | +$620K |
|
|
LND
2523
BrasilAgro
LND
$380M
| $619K | ﹤0.01% |
173,500
+34,000
| +24% | +$131K |
|
|
ADAG
2524
Adagene
ADAG
$234M
| $615K | ﹤0.01% |
146,500
+111,967
| +324% | +$421K |
|
2525
Xilio Therapeutics
XLO
$58.6M
| $615K | ﹤0.01% |
64,153
+14,587
| +29% | +$122K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.